cache/89f766ad26ef08d3692a413bb90df99f1f1ea1bb4ef4b8e10c78cf32a1f758a4

EURONEXT:MDMA

Pharmala Biotech Holdings Inc.

  • Stock

Last Close

0.11

26/07 13:55

Volume Today

15.54K

Avg: 2.03M

PE Ratio

−61.79

PFCF: −36.83

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Nov '21
Feb '22
May '22
Aug '22
Nov '22
Feb '23
May '23
Aug '23
Nov '23
Feb '24
net income
-302.72K
-
-285.33K
5.74%
-206.08K
27.78%
-191.45K
7.10%
-288.50K
50.69%
-72.27K
74.95%
-338.74K
368.72%
-80.30K
76.29%
36.48K
145.43%
-222.57K
710.16%
depreciation and amortization
253
-
445
75.89%
445
0%
10.99K
2,370.11%
13.18K
19.89%
13.18K
0%
13.18K
0%
13.23K
0.40%
15.79K
19.36%
15.78K
0.09%
deferred income tax
-166.55K
-
-142.22K
14.60%
-3.45K
97.57%
26.80K
876.25%
stock based compensation
63.48K
-
33.04K
47.96%
14.47K
56.21%
125.54K
767.80%
40.75K
67.54%
17.25K
57.68%
4.45K
74.20%
5.28K
18.61%
18.78K
255.82%
change in working capital
-32.87K
-
229.81K
799.16%
-218.71K
195.17%
133.32K
160.96%
233.13K
74.87%
48.70K
79.11%
7.55K
84.49%
87.47K
1,057.80%
-171.32K
295.86%
134.01K
178.22%
accounts receivables
95K
-
-23.22K
124.44%
-50.21K
116.27%
12.60K
125.09%
60.83K
382.92%
-137.76K
326.48%
15.12K
110.98%
-19.20K
227.01%
inventory
-2.83K
-
95.94K
-
112.03K
16.77%
accounts payables
160.94K
-
31.09K
80.68%
144.30K
364.12%
other working capital
-313.71K
-
159.36K
150.80%
283.34K
77.80%
36.10K
87.26%
-53.27K
247.56%
-31.64K
40.61%
-329.57K
941.58%
8.92K
102.71%
other non cash items
166.55K
-
142.22K
14.60%
3.45K
97.57%
-26.80K
876.25%
-57.20K
113.45%
114.59K
300.35%
-127.37K
211.15%
net cash provided by operating activities
-271.85K
-
-22.04K
91.89%
-409.88K
1,759.38%
78.41K
119.13%
-1.44K
101.83%
6.85K
577.30%
-313.56K
4,674.83%
-31.52K
89.95%
14.32K
145.44%
-106.61K
844.50%
investments in property plant and equipment
-53.44K
-
-276.45K
417.33%
-237.84K
13.97%
-427.14K
79.59%
-120.23K
71.85%
-44.70K
62.82%
-72.36K
61.89%
-269.44K
272.33%
-56.51K
79.03%
-75.89K
34.29%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-53.44K
-
-276.45K
417.33%
-237.84K
13.97%
-427.14K
79.59%
-120.23K
71.85%
-44.70K
62.82%
-72.36K
61.89%
-269.44K
272.33%
-56.51K
79.03%
-75.89K
34.29%
debt repayment
common stock issued
39.10K
-
150.19K
284.13%
70K
-
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities
39.10K
-
150.19K
284.13%
70K
-
effect of forex changes on cash
net change in cash
-325.29K
-
-298.49K
8.24%
-647.72K
117.00%
-348.74K
46.16%
-121.67K
65.11%
1.25K
101.03%
-235.73K
18,913.17%
-300.95K
27.67%
27.80K
109.24%
-182.50K
756.36%
cash at beginning of period
2.47M
-
2.15M
13.16%
1.85M
13.90%
1.20M
35.04%
852.14K
29.04%
730.47K
14.28%
731.72K
0.17%
495.99K
32.22%
195.04K
60.68%
222.85K
14.26%
cash at end of period
2.15M
-
1.85M
13.90%
1.20M
35.04%
852.14K
29.04%
730.47K
14.28%
731.72K
0.17%
495.99K
32.22%
195.04K
60.68%
222.85K
14.26%
40.35K
81.89%
operating cash flow
-271.85K
-
-22.04K
91.89%
-409.88K
1,759.38%
78.41K
119.13%
-1.44K
101.83%
6.85K
577.30%
-313.56K
4,674.83%
-31.52K
89.95%
14.32K
145.44%
-106.61K
844.50%
capital expenditure
-53.44K
-
-276.45K
417.33%
-237.84K
13.97%
-427.14K
79.59%
-120.23K
71.85%
-44.70K
62.82%
-72.36K
61.89%
-269.44K
272.33%
-56.51K
79.03%
-75.89K
34.29%
free cash flow
-325.29K
-
-298.49K
8.24%
-647.72K
117.00%
-348.74K
46.16%
-121.67K
65.11%
-37.85K
68.89%
-385.92K
919.70%
-300.95K
22.02%
-42.20K
85.98%
-182.50K
332.52%

All numbers in (except ratios and percentages)